Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 246

1.

FTO genetic variants, dietary intake and body mass index: insights from 177 330 individuals.

Qi Q, Kilpeläinen TO, Downer MK, Tanaka T, Smith CE, Sluijs I, Sonestedt E, Chu AY, Renström F, Lin X, Angquist LH, Huang J, Liu Z, Li Y, Asif Ali M, Xu M, Ahluwalia TS, Boer JM, Chen P, Daimon M, Eriksson J, Perola M, Friedlander Y, Gao YT, Heppe DH, Holloway JW, Houston DK, Kanoni S, Kim YM, Laaksonen MA, Jääskeläinen T, Lee NR, Lehtimäki T, Lemaitre RN, Lu W, Luben RN, Manichaikul A, Männistö S, Marques-Vidal P, Monda KL, Ngwa JS, Perusse L, van Rooij FJ, Xiang YB, Wen W, Wojczynski MK, Zhu J, Borecki IB, Bouchard C, Cai Q, Cooper C, Dedoussis GV, Deloukas P, Ferrucci L, Forouhi NG, Hansen T, Christiansen L, Hofman A, Johansson I, Jørgensen T, Karasawa S, Khaw KT, Kim MK, Kristiansson K, Li H, Lin X, Liu Y, Lohman KK, Long J, Mikkilä V, Mozaffarian D, North K, Pedersen O, Raitakari O, Rissanen H, Tuomilehto J, van der Schouw YT, Uitterlinden AG, Carola Zillikens M, Franco OH, Shyong Tai E, Ou Shu X, Siscovick DS, Toft U, Monique Verschuren WM, Vollenweider P, Wareham NJ, Witteman JC, Zheng W, Ridker PM, Kang JH, Liang L, Jensen MK, Curhan GC, Pasquale LR, Hunter DJ, Mohlke KL, Uusitupa M, Adrienne Cupples L, Rankinen T, Orho-Melander M, Wang T, Chasman DI, Franks PW, Sørensen TI, Hu FB, Loos RJ, Nettleton JA, Qi L.

Hum Mol Genet. 2014 Aug 7. pii: ddu411. [Epub ahead of print]

PMID:
25104851
[PubMed - as supplied by publisher]
2.

Associations between mood, anxiety or substance use disorders and inflammatory markers after adjustment for multiple covariates in a population-based study.

Glaus J, Vandeleur CL, von Känel R, Lasserre AM, Strippoli MP, Gholam-Rezaee M, Castelao E, Marques-Vidal P, Bovet P, Merikangas K, Mooser V, Waeber G, Vollenweider P, Aubry JM, Preisig M.

J Psychiatr Res. 2014 Jul 22. pii: S0022-3956(14)00209-X. doi: 10.1016/j.jpsychires.2014.07.012. [Epub ahead of print]

PMID:
25088287
[PubMed - as supplied by publisher]
3.

Novel Approach Identifies SNPs in SLC2A10 and KCNK9 with Evidence for Parent-of-Origin Effect on Body Mass Index.

Hoggart CJ, Venturini G, Mangino M, Gomez F, Ascari G, Zhao JH, Teumer A, Winkler TW, Tšernikova N, Luan J, Mihailov E, Ehret GB, Zhang W, Lamparter D, Esko T, Macé A, Rüeger S, Bochud PY, Barcella M, Dauvilliers Y, Benyamin B, Evans DM, Hayward C, Lopez MF, Franke L, Russo A, Heid IM, Salvi E, Vendantam S, Arking DE, Boerwinkle E, Chambers JC, Fiorito G, Grallert H, Guarrera S, Homuth G, Huffman JE, Porteous D; Generation Scotland Consortium; LifeLines Cohort study; GIANT Consortium, Moradpour D, Iranzo A, Hebebrand J, Kemp JP, Lammers GJ, Aubert V, Heim MH, Martin NG, Montgomery GW, Peraita-Adrados R, Santamaria J, Negro F, Schmidt CO, Scott RA, Spector TD, Strauch K, Völzke H, Wareham NJ, Yuan W, Bell JT, Chakravarti A, Kooner JS, Peters A, Matullo G, Wallaschofski H, Whitfield JB, Paccaud F, Vollenweider P, Bergmann S, Beckmann JS, Tafti M, Hastie ND, Cusi D, Bochud M, Frayling TM, Metspalu A, Jarvelin MR, Scherag A, Smith GD, Borecki IB, Rousson V, Hirschhorn JN, Rivolta C, Loos RJ, Kutalik Z.

PLoS Genet. 2014 Jul 31;10(7):e1004508. doi: 10.1371/journal.pgen.1004508. eCollection 2014 Jul.

PMID:
25078964
[PubMed - in process]
Free PMC Article
4.

Clinical and biological determinants of kidney outcomes in a population-based cohort study.

Guessous I, Ponte B, Marques-Vidal P, Paccaud F, Gaspoz JM, Burnier M, Waeber G, Vollenweider P, Bochud M.

Kidney Blood Press Res. 2014;39(1):74-85. doi: 10.1159/000355779. Epub 2014 Jun 23.

PMID:
25011916
[PubMed - in process]
5.

Markers of iron metabolism and metabolic syndrome in Swiss adults.

Kilani N, Waeber G, Vollenweider P, Marques-Vidal P.

Nutr Metab Cardiovasc Dis. 2014 Aug;24(8):e28-9. doi: 10.1016/j.numecd.2014.04.018. Epub 2014 May 27. No abstract available.

PMID:
24974320
[PubMed - in process]
6.

Depression with atypical features and increase in obesity, body mass index, waist circumference, and fat mass: a prospective, population-based study.

Lasserre AM, Glaus J, Vandeleur CL, Marques-Vidal P, Vaucher J, Bastardot F, Waeber G, Vollenweider P, Preisig M.

JAMA Psychiatry. 2014 Aug 1;71(8):880-8. doi: 10.1001/jamapsychiatry.2014.411.

PMID:
24898270
[PubMed - in process]
7.

Ozone phytotoxic potential with regard to fragments of the Atlantic Semi-deciduous Forest downwind of Sao Paulo, Brazil.

Moura BB, Alves ES, de Souza SR, Domingos M, Vollenweider P.

Environ Pollut. 2014 Sep;192:65-73. doi: 10.1016/j.envpol.2014.05.014. Epub 2014 Jun 2.

PMID:
24892227
[PubMed - in process]
8.

Seasonality of cardiovascular risk factors: an analysis including over 230 000 participants in 15 countries.

Marti-Soler H, Gubelmann C, Aeschbacher S, Alves L, Bobak M, Bongard V, Clays E, de Gaetano G, Di Castelnuovo A, Elosua R, Ferrieres J, Guessous I, Igland J, Jørgensen T, Nikitin Y, O'Doherty MG, Palmieri L, Ramos R, Simons J, Sulo G, Vanuzzo D, Vila J, Barros H, Borglykke A, Conen D, De Bacquer D, Donfrancesco C, Gaspoz JM, Giampaoli S, Giles GG, Iacoviello L, Kee F, Kubinova R, Malyutina S, Marrugat J, Prescott E, Ruidavets JB, Scragg R, Simons LA, Tamosiunas A, Tell GS, Vollenweider P, Marques-Vidal P.

Heart. 2014 May 30. pii: heartjnl-2014-305623. doi: 10.1136/heartjnl-2014-305623. [Epub ahead of print]

PMID:
24879630
[PubMed - as supplied by publisher]
9.

Twenty-year differences in cardiovascular risk factor levels in a Swiss canton.

Pommier C, Waeber G, Vollenweider P, Marques-Vidal P.

Int J Cardiol. 2014 Jun 1;174(1):176-8. doi: 10.1016/j.ijcard.2014.03.188. Epub 2014 Apr 6. No abstract available.

PMID:
24746539
[PubMed - in process]
10.

Do you want some spiritual support? Different rates of positive response to chaplains' versus nurses' offer.

Martinuz M, Dürst AV, Faouzi M, Pétremand D, Reichel V, Ortega B, Waeber G, Vollenweider P.

J Pastoral Care Counsel. 2013 Sep-Dec;67(3-4):3.

PMID:
24720242
[PubMed - indexed for MEDLINE]
11.

Antihypertensive drug treatment changes in the general population: the CoLaus study.

Christe V, Waeber G, Vollenweider P, Marques-Vidal P.

BMC Pharmacol Toxicol. 2014 Mar 31;15(1):20. doi: 10.1186/2050-6511-15-20.

PMID:
24685255
[PubMed - in process]
Free PMC Article
12.

Association of education and receiving social transfers with allostatic load in the Swiss population-based CoLaus study.

Nicod E, Stringhini S, Marques-Vidal P, Paccaud F, Waeber G, Lamiraud K, Vollenweider P, Bochud M.

Prev Med. 2014 Jun;63:63-71. doi: 10.1016/j.ypmed.2014.03.013. Epub 2014 Mar 19.

PMID:
24657126
[PubMed - in process]
13.

Cytokines and hs-CRP levels in individuals treated with low-dose aspirin for cardiovascular prevention: a population-based study (CoLaus Study).

Vaucher J, Marques-Vidal P, Waeber G, Vollenweider P.

Cytokine. 2014 Apr;66(2):95-100. doi: 10.1016/j.cyto.2014.01.003. Epub 2014 Feb 3.

PMID:
24594292
[PubMed - in process]
14.

Genome-wide association study of metabolic traits reveals novel gene-metabolite-disease links.

Rueedi R, Ledda M, Nicholls AW, Salek RM, Marques-Vidal P, Morya E, Sameshima K, Montoliu I, Da Silva L, Collino S, Martin FP, Rezzi S, Steinbeck C, Waterworth DM, Waeber G, Vollenweider P, Beckmann JS, Le Coutre J, Mooser V, Bergmann S, Genick UK, Kutalik Z.

PLoS Genet. 2014 Feb 20;10(2):e1004132. doi: 10.1371/journal.pgen.1004132. eCollection 2014 Feb.

PMID:
24586186
[PubMed - in process]
Free PMC Article
15.

Common Variants in UMOD Associate with Urinary Uromodulin Levels: A Meta-Analysis.

Olden M, Corre T, Hayward C, Toniolo D, Ulivi S, Gasparini P, Pistis G, Hwang SJ, Bergmann S, Campbell H, Cocca M, Gandin I, Girotto G, Glaudemans B, Hastie ND, Loffing J, Polasek O, Rampoldi L, Rudan I, Sala C, Traglia M, Vollenweider P, Vuckovic D, Youhanna S, Weber J, Wright AF, Kutalik Z, Bochud M, Fox CS, Devuyst O.

J Am Soc Nephrol. 2014 Aug;25(8):1869-82. doi: 10.1681/ASN.2013070781. Epub 2014 Feb 27.

PMID:
24578125
[PubMed - in process]
16.

Population and economic impact of the 2013 ACC/AHA guidelines compared with European guidelines to prevent cardiovascular disease.

Vaucher J, Marques-Vidal P, Preisig M, Waeber G, Vollenweider P.

Eur Heart J. 2014 Apr;35(15):958-9. doi: 10.1093/eurheartj/ehu064. Epub 2014 Feb 25. No abstract available.

PMID:
24569030
[PubMed - in process]
17.

Urotensin-II system in genetic control of blood pressure and renal function.

Debiec R, Christofidou P, Denniff M, Bloomer LD, Bogdanski P, Wojnar L, Musialik K, Charchar FJ, Thompson JR, Waterworth D, Song K, Vollenweider P, Waeber G, Zukowska-Szczechowska E, Samani NJ, Lambert D, Tomaszewski M.

PLoS One. 2013 Dec 31;8(12):e83137. doi: 10.1371/journal.pone.0083137. eCollection 2013.

PMID:
24391740
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

[Dysmetabolic hyperferritinemia: a new target for treatment?].

Waeber G, Vollenweider P, Marques-Vidal PM.

Rev Med Suisse. 2013 Oct 30;9(404):2002, 2004-7. French.

PMID:
24313052
[PubMed - indexed for MEDLINE]
19.

[Complete blood counts: new parameters].

Lambert JF, Vollenweider P.

Rev Med Suisse. 2013 Oct 30;9(404):1998-2001. French.

PMID:
24313051
[PubMed - indexed for MEDLINE]
20.

Associations of serum uric acid and SLC2A9 variant with depressive and anxiety disorders: a population-based study.

Lyngdoh T, Bochud M, Glaus J, Castelao E, Waeber G, Vollenweider P, Preisig M.

PLoS One. 2013 Oct 29;8(10):e76336. doi: 10.1371/journal.pone.0076336. eCollection 2013.

PMID:
24204615
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk